Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
      • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
JIM

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising

Banner year for the Journal of Investigative Medicine

Richard McCallum
DOI: 10.1136/jim-2022-002441 Published 11 April 2022
Richard McCallum
Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Colleagues, I am writing to update you on the productivity of the Journal of Investigative Medicine (JIM) in 2021. I am very happy to report that indeed it was a banner year for the journal, as evidenced by a 17% increase in submissions compared with 2020 and a 17% increase in acceptances—both continuing the upward curve that began in 2020 (figure 1). This suggests that, during this COVID-19 pandemic, investigators found the time to update and finalize their data and complete manuscripts that may have been sitting on their desks for some time. With less opportunity to travel, attend meetings, and present abstracts in person, authors also may have chosen to expedite publication of their work.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Submissions and Acceptances

The overall acceptance rate for original research was 27% and for all submissions the acceptance rate was 33%. The instant rejection rate increased from 28% in 2020 to 40%.

The time to first decision on all submissions averaged 1 month and the time to first decision for reviewed submissions averaged 6–7 weeks. To decrease our decision times, we have been focusing on trying to expedite the time required for identifying reviewers for each manuscript, including recommending that Editorial Board members with expertise in a specific field be approached as reviewers. Currently, the mean time to final acceptance for all papers is approaching 3 months. While overall these data are stable, there is room for further streamlining this process.

While the majority of accepted submissions are from the USA, followed by China, JIM continues to publish content from a global authorship. Not unexpectedly, the most downloaded articles in 2021 from JIM were dominated by COVID-19. JIM’s most popular article type, as evidenced by download data, are Original Research articles, followed by Brief Reports, Reviews, Letters to the Editor, Editorials, Research Tools and Issues, Experimental Biology Symposia, and Faculty Development.

Open access in JIM continues to increase and is now approaching 20% of all published papers. Website usage has been a focus of our Editorial Board efforts and we saw a very solid improvement in 2021, as summarized in figure 2, with an approximate 30% overall increase in traffic accompanied by a 47% increase in google traffic and a 93% increase in PubMed searches over 2020. JIM continues to be a worldwide journal, with traffic seen from all continents and major countries. Another component of our increased visibility is the monthly podcast, where the number of listens increased by 14% over 2020. I began this soon after becoming Editor-in-Chief and we now have over 20 podcasts highlighting articles and authors from JIM, as well as guest speakers discussing the ‘Disease of the Month’, the most recent of which is our March podcast, recorded with Dr Al-Bayati from Texas Tech El Paso for Colon Cancer Awareness Month. I encourage our members and readers to please notify me should you have a special topic of interest.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Overall Website Usage

In the fall of 2021, we conducted a survey to learn more about the habits of our authors and readers. Results showed that:

  • 84% of JIM responders find the articles are of interest;

  • 78% of JIM responders engage with the journal more than occasionally;

  • 83% of JIM responders find the subscription valuable;

  • two out of three reference JIM when writing their manuscripts.

In addition, the top five ranked article types were identified as Original Research, Brief Reports, Research Tools and Issues, Reviews, and Faculty Development.

This summary would not be complete without recognizing the key roles of our very hard working and outstanding Associate Editors, ably assisted by the expertise of our Editorial Board Members. I want to recognize Dr John Dickinson, who is now the Social Media Editor for JIM, for prioritizing this effort. Thanks to my former Editorial Assistant at Texas Tech, El Paso, Karina Espino, who oversaw my entry into the Twitter world. Special thanks to Kathleen Lyons of BMJ for her guidance and to Hannah Martin, who so ably handles production of our journal. Thanks also to our Editorial Production Assistants Chloe Tuck and Rachael Wright who ‘conduct the orchestra’, moving submissions efficiently through the review and revisions process and finalizing acceptance, and to my new assistant at Texas Tech, El Paso, Isabel Aguirre. Special thanks for the stewardship of Aurelie Alger and Taylor Baumgartner at the AFMR office, as well as Leslie Yerman, who is retiring but will be remembered for her many contributions to JIM.

So, colleagues, let me say a sincere THANK YOU for your continued support and commitment to JIM and AFMR. It is a special privilege for me to be the Editor-in-Chief of your journal. I will be counting on your assistance as I continue guiding the ship this year. Please feel free to email your thoughts and suggestions to richard.mccallum@ttuhsc.edu.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

Not applicable.

Footnotes

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

PreviousNext
Back to top
Vol 70 Issue 4 Table of Contents
Journal of Investigative Medicine: 70 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Banner year for the Journal of Investigative Medicine
(Your Name) has sent you a message from JIM
(Your Name) thought you would like to see the JIM web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Banner year for the Journal of Investigative Medicine
Richard McCallum
Journal of Investigative Medicine Apr 2022, 70 (4) 859-860; DOI: 10.1136/jim-2022-002441

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Banner year for the Journal of Investigative Medicine
Richard McCallum
Journal of Investigative Medicine Apr 2022, 70 (4) 859-860; DOI: 10.1136/jim-2022-002441
Download PDF

Share
Banner year for the Journal of Investigative Medicine
Richard McCallum
Journal of Investigative Medicine Apr 2022, 70 (4) 859-860; DOI: 10.1136/jim-2022-002441
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Ethics statements
    • Footnotes
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Saying goodbye and remembering
  • COVID-19 vaccine efficacy in a rapidly changing landscape
  • New agents for sickle cell disease: patient perceptions of benefit in the real world
Show more Editorial

Similar Articles

 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Subscribe
  • Thank you to our reviewers
  • American Federation for Medical Research

AUTHORS

  • Information for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2023 American Federation for Medical Research